Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 1
1977 1
1978 1
1984 1
1989 2
1990 1
1991 3
1992 1
1993 2
1994 5
1996 1
1997 1
1998 1
1999 2
2000 1
2002 1
2004 1
2005 1
2006 1
2011 1
2012 1
2013 1
2014 4
2015 2
2016 3
2017 4
2018 4
2019 5
2020 5
2021 6
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage.
Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, Gagné A, Joubert P, De Sordi L, Debarbieux L, Simon S, Scarlata CM, Ayyoub M, Palermo B, Facciolo F, Boidot R, Wheeler R, Boneca IG, Sztupinszki Z, Papp K, Csabai I, Pasolli E, Segata N, Lopez-Otin C, Szallasi Z, Andre F, Iebba V, Quiniou V, Klatzmann D, Boukhalil J, Khelaifia S, Raoult D, Albiges L, Escudier B, Eggermont A, Mami-Chouaib F, Nistico P, Ghiringhelli F, Routy B, Labarrière N, Cattoir V, Kroemer G, Zitvogel L. Fluckiger A, et al. Among authors: loos f. Science. 2020 Aug 21;369(6506):936-942. doi: 10.1126/science.aax0701. Science. 2020. PMID: 32820119 Free article.
Aspirin Recapitulates Features of Caloric Restriction.
Pietrocola F, Castoldi F, Markaki M, Lachkar S, Chen G, Enot DP, Durand S, Bossut N, Tong M, Malik SA, Loos F, Dupont N, Mariño G, Abdelkader N, Madeo F, Maiuri MC, Kroemer R, Codogno P, Sadoshima J, Tavernarakis N, Kroemer G. Pietrocola F, et al. Among authors: loos f. Cell Rep. 2018 Feb 27;22(9):2395-2407. doi: 10.1016/j.celrep.2018.02.024. Cell Rep. 2018. PMID: 29490275 Free PMC article.
Strategies to enable the adoption of animal biotechnology to sustainably improve global food safety and security.
Tizard M, Hallerman E, Fahrenkrug S, Newell-McGloughlin M, Gibson J, de Loos F, Wagner S, Laible G, Han JY, D'Occhio M, Kelly L, Lowenthal J, Gobius K, Silva P, Cooper C, Doran T. Tizard M, et al. Among authors: de loos f. Transgenic Res. 2016 Oct;25(5):575-95. doi: 10.1007/s11248-016-9965-1. Epub 2016 May 31. Transgenic Res. 2016. PMID: 27246007 Review.
Immunosuppression by Mutated Calreticulin Released from Malignant Cells.
Liu P, Zhao L, Loos F, Marty C, Xie W, Martins I, Lachkar S, Qu B, Waeckel-Énée E, Plo I, Vainchenker W, Perez F, Rodriguez D, López-Otin C, van Endert P, Zitvogel L, Kepp O, Kroemer G. Liu P, et al. Among authors: loos f. Mol Cell. 2020 Feb 20;77(4):748-760.e9. doi: 10.1016/j.molcel.2019.11.004. Epub 2019 Nov 27. Mol Cell. 2020. PMID: 31785928 Free article.
Epigenetic anticancer agents cause HMGB1 release in vivo.
Liu P, Zhao L, Loos F, Iribarren K, Kepp O, Kroemer G. Liu P, et al. Among authors: loos f. Oncoimmunology. 2018 Feb 14;7(6):e1431090. doi: 10.1080/2162402X.2018.1431090. eCollection 2018. Oncoimmunology. 2018. PMID: 29872561 Free PMC article.
Identification of pharmacological agents that induce HMGB1 release.
Liu P, Zhao L, Loos F, Iribarren K, Lachkar S, Zhou H, Gomes-da-Silva LC, Chen G, Bezu L, Boncompain G, Perez F, Zitvogel L, Kepp O, Kroemer G. Liu P, et al. Among authors: loos f. Sci Rep. 2017 Nov 2;7(1):14915. doi: 10.1038/s41598-017-14848-1. Sci Rep. 2017. PMID: 29097772 Free PMC article.
A novel perspective on pharmaceutical R&D costs: opportunities for reductions.
van der Schans S, De Loos F, Boersma C, Postma MJ, Büller H. van der Schans S, et al. Among authors: de loos f. Expert Rev Pharmacoecon Outcomes Res. 2022 Mar;22(2):167-175. doi: 10.1080/14737167.2022.1987219. Epub 2021 Oct 21. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34595997
64 results